Academic journal article Health Care Financing Review

Prostate Cancer Screening Deemed Cost-Effective in Recent Report

Academic journal article Health Care Financing Review

Prostate Cancer Screening Deemed Cost-Effective in Recent Report

Article excerpt

Prostate cancer is the second leading cause of cancer death in American men. Approximately 38,000 deaths and 200,000 newly diagnosed cases were reported in 1994. Tens of thousands of other men will suffer pain and a deterioration in their quality of life from this malignancy, which has its highest incidence among African-American men. The American Urological Association (AUA), representing 10,000 urologists worldwide, is encouraged that the Office of Technology Assessment (OTA) has issued a report that concludes that "prostate cancer screening could indeed be as cost-effective as other disease screening services already covered by Medicare."

OTA's report, Preventive Services under Medicare: Costs and Effectiveness of Prostate Cancer Screening Among Elderly Men, concludes that, "Given the state of current knowledge about prostate cancer, it may be reasonable for Medicare to consider reimbursement of the screening test. Reimbursement could be seen as ensuring that out-of-pocket screening expenses (however small) not impede well-informed discussion and decisionmaking between physician and patient."

According to AUA, it is vitally important that all men have access to prostate screening assessment (PSA) surveillance. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.